紅血球生成刺激劑
參考文獻

1 2 3 4 5  . US Food and Drug Administration – Drug Safety Information. 2017-03-31. （原始内容存档于2022-04-14）.
1 2 3 4 5 6  Banzi, Rita; Gerardi, Chiara.  (PDF) (报告). WHO. 2016-12-23. WHO EML 2016–2017, Version 3. （原始内容 (PDF)存档于2020-08-31）.
↑   (PDF). FDA.   [2017-12-13]. （原始内容存档 (PDF)于2019-12-10）.
1 2 3  . Drugs.com.   [2017-12-13]. （原始内容存档于2017-12-14）.
↑   69. British Medical Association. 2015: 666–671. ISBN 9780857111562.
↑  World Health Organization. . Geneva: World Health Organization. 2019. hdl:10665/325771 . WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
1 2  Aapro, M. S.; Link, H. . The Oncologist. 2008, 13: 33–36. PMID 18458123. doi:10.1634/theoncologist.13-S3-33.
↑  American Society of Nephrology,  (PDF), Choosing Wisely: an initiative of the ABIM Foundation (American Society of Nephrology),   [2012-08-17], （原始内容 (PDF)存档于2012-04-16）
↑  Aher, SM; Ohlsson, A. . The Cochrane Database of Systematic Reviews. 2020 -01-28, 1 (1): CD004868. PMC 6986694 . PMID 31990982. doi:10.1002/14651858.CD004868.pub6.  请检查|date=中的日期值 (帮助)
↑  Kaufner L, Heymann C. . Cochrane Database of Systematic Reviews. 2020, 2020 (8): CD012451. PMC 8095002 . PMID 32790892. doi:10.1002/14651858.CD012451.pub2.
↑  Chung EY, Palmer SC, Saglimbene VM, Craig JC, Tonelli M, Strippoli GF. . The Cochrane Database of Systematic Reviews. February 2023, 2023 (2): CD010590. PMC 9924302 . PMID 36791280. doi:10.1002/14651858.CD010590.pub3.
↑  Burtis, C.A.; Ashwood, E.R. and Bruns, D.E. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. 5th Edition. Elsevier. pp 1554
↑  Kalantar-Zadeh, Kamyar. . American Journal of Nephrology. 2017-02-01, 45 (3): 235–247  [2024-10-17]. doi:10.1159/000455387.
↑  . Amgen.com.   [2009-04-29]. （原始内容存档于2006-10-18）.
↑  . European Medicines Agency (EMA). 2020-01-13  [2020-03-10]. （原始内容存档于2020-11-12）.
↑  . European Medicines Agency (EMA). 2019-10-31  [2020-03-10]. （原始内容存档于2019-12-30）.
↑  . Ortho Biotech Products.   [2009-04-29]. （原始内容存档于2009-10-26）.
↑  . probiomed.com.mx.   [2018-03-21]. （原始内容存档于2018-03-26）.
↑  . European Medicines Agency (EMA). 2019-10-08  [2020-03-10]. （原始内容存档于2020-03-23）.
↑  . European Medicines Agency (EMA). 2019-12-20  [2020-03-10]. （原始内容存档于2019-12-29）.
1 2  . European Medicines Agency (EMA). 2009-04-23  [2020-03-10]. （原始内容存档于2020-08-11）.
↑  . European Medicines Agency (EMA). 2020-03-10  [2020-03-10]. （原始内容存档于2020-10-22）.
↑  . European Medicines Agency (EMA). 2020-01-14  [2020-03-10]. （原始内容存档于2019-12-30）.
↑  Macdougall IC. . Seminars in Nephrology. Jul 2000, 20 (4): 375–81. PMID 10928340.
↑  . Bleacher Report. December 2011  [2011-12-22]. （原始内容存档于2011-12-08）.
↑  Jelkmann W, Lundby C.  (PDF). Blood. Sep 2011, 118 (9): 2395–404  [2024-10-28]. PMID 21652677. S2CID 2685044. doi:10.1182/blood-2011-02-303271. （原始内容存档 (PDF)于2021-08-28）.
↑  emmanuelobeagu@yahoo.com; obeagu.emmanuel@mouau.edu.ng.  (PDF). International Journal of Advanced Research in Biological Sciences: 35–47.   [2024-10-17]. （原始内容存档 (PDF)于2020-07-22）.
↑  History of the Swiss Laboratory for Doping Analyses 的存檔，存档日期2016-03-29., www.doping.chuv.ch (page visited on 2014-06-11).
↑  Steeg JL. . USA Today. 2007-02-28  [2009-03-31]. （原始内容存档于2009-02-26）.
↑  "FDA Reports New Risks Posed by Anemia Drugs" Associated Press story in The Washington Post (2012-08-08)
↑  Lasne F, Martin L, Crepin N, de Ceaurriz J. . Analytical Biochemistry. Dec 2002, 311 (2): 119–26. PMID 12470670. doi:10.1016/S0003-2697(02)00407-4.
↑  Kohler M, Ayotte C, Desharnais P, Flenker U, Lüdke S, Thevis M, Völker-Schänzer E, Schänzer W. . International Journal of Sports Medicine. Jan 2008, 29 (1): 1–6. PMID 18050057. S2CID 11677786. doi:10.1055/s-2007-989369.
↑  Jelkmann W. . Open Journal of Hematology. 2012, 3: 3–6. doi:10.13055/ojhmt_3_1_6.121211.
↑  . The Economist. 2014-02-08  [2024-10-28]. （原始内容存档于2017-08-16）.
↑  Lodewijkx HF, Brouwer B. . Research Quarterly for Exercise and Sport. Dec 2011, 82 (4): 740–54. PMID 22276416. S2CID 34350476. doi:10.1080/02701367.2011.10599811.
↑  Lundby C, Robach P, Boushel R, Thomsen JJ, Rasmussen P, Koskolou M, Calbet JA. . Journal of Applied Physiology. Aug 2008, 105 (2): 581–7. PMID 18535134. doi:10.1152/japplphysiol.90484.2008. hdl:10553/6534 .
↑  Harrison C. . Sport Monthly. chrisharrisonwriting. 2003-03-01. （原始内容存档于2014-02-26）.
↑  Martin DT, Ashenden M, Parisotto R, Pyne D, Hahn AG. . Sports Science. March–April 1997  [2024-10-28]. （原始内容存档于2019-08-29）.
↑  . BBC. 5 June 1999  [30 June 2011]. （原始内容存档于2013-10-29）.
↑  Millar R. . Cycling News. 2003-10-23  [2024-10-28]. （原始内容存档于2014-11-04）.
↑  United States Anti Doping Agency.  (PDF). USADA.   [2012-10-28]. （原始内容存档 (PDF)于2012-10-29）.
↑  "A lifetime ban: Does the time fit the crime?" Velo News, 12/16/13
↑  Wathion, Noël.  (PDF). European Medicines Agency.   [2015-08-31]. （原始内容 (PDF)存档于2015-09-24）.
↑  Bauer, Kristian. . London: A & C Black. 2011: 35. ISBN 978-1-4081-3333-0.